MedSci Healthcare Holdings Limited

Research MedSci Healthcare Holdings Limited (2415.HK) on Bullrun: market cap HKD 465.39M, P/E 28.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 465.39M; P/E is 28.3.

Peer valuation comparison

Latest P/E is 28.33x versus a Healthcare sector median of 21.69x (30.6% above).

Latest P/E is 28.33x versus a China median of 16.26x (74.2% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 270.37MCNY 17.94MCNY 1.99M59.3%0.03CNY 367.73MCNY 6.26MCNY 1.18B
FY2024CNY 260.62MCNY 24.97MCNY 54.47M62.2%0.05CNY 366.94MCNY 2.00MCNY 1.17B
FY2023CNY 349.19MCNY 55.04MCNY 36.09M62.0%0.08CNY 181.92MCNY 4.64MCNY 1.12B
FY2022CNY 348.95M-CNY 99.88M-CNY 16.21M59.1%-0.16CNY 320.68MCNY 9.59M-CNY 142.26M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 465.39M28.3n/a0.02

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.02 HKD.

YearDividends/share
FY20250.01 CNY

About MedSci Healthcare Holdings Limited

MedSci Healthcare Holdings Limited, an investment holding company, operates as a physician platform solutions in the People's Republic of China and the United States. The company offers precision omni-channel marketing solutions, including precision detailing, medical content creation, and online survey services; physician platform solutions, such as medical knowledge and clinical study assistance services; data and artificial intelligence solutions;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is MedSci Healthcare Holdings Limited's market cap?

MedSci Healthcare Holdings Limited's market capitalization is HKD 465.39M.

What is MedSci Healthcare Holdings Limited's P/E ratio?

MedSci Healthcare Holdings Limited's price-to-earnings (P/E) ratio is 28.3.

What does MedSci Healthcare Holdings Limited do?

MedSci Healthcare Holdings Limited, an investment holding company, operates as a physician platform solutions in the People's Republic of China and the United States. The company offers precision omni-channel marketing solutions, including precision detailing, medical content creation, and online survey services; physician platform solutions, such as medical knowledge and clinical study assistance services; data and artificial intelligence solutions; and real-world study solutions comprising designing, administration, and execution of digital real-world evidence-based research.